1578. Nitrofurantoin Prophylaxis for Urinary Tract Infection (UTI) in Veterans with Spinal Cord Injury (SCI)
Session: Poster Abstract Session: Clinical Infectious Diseases: UTIs
Saturday, October 10, 2015
Room: Poster Hall
Background: SCI is associated with increased risk of developing UTIs which are a frequent cause of morbidity and antimicrobial use. Nitrofurantoin (NF) is commonly used for treatment of UTI in SCI patients, but data on the efficacy of NF for UTI prophylaxis in this population is scarce. Thus, the objective of this study was to assess the impact of NF for symptomatic UTI prophylaxis on health outcomes in Veterans with SCI. 

Methods: This retrospective case-case-control study evaluated Veterans with SCI cared for at VA facilities from October 2012-September 2013.  SCI patients continuously receiving NF for UTI prophylaxis (Case1 group) were compared to patients who had a history of at least 90 days of NF for UTI prophylaxis (Case2 group).  Cases were matched to controls cared for at the same facility during the study period who had not received prophylactic treatment and had a history of ≥3 positive urine cultures.  Demographics and health outcomes were compared using Chi square, Fisher Exact, and Wilcoxon-Mann-Whitney tests as appropriate; Bonferroni was used to adjust for multiple comparisons.

Results: 122 SCI patients were identified in the Case1 group (mean age=59.6+11.1; range=25-84; 89% men) and 103 in the Case2 group (mean age=61.1+13.8; range=21-92; 96% men). There was no difference in NF dose for the case groups (p=NS).  Cases were matched to 277 controls (mean age=61.4+11.9; range=22-88; 95% men; p=NS). Controls had a significantly higher Charlson Index as compared to cases (p≤0.0001).  The Case1 group had a significant reduction in symptomatic UTIs as compared to the Case2 group (30% vs. 55% respectively, p=0.02).  Case groups were more likely to have isolates resistant to NF (p≤0.0001), while multi-drug resistant organisms (resistant to ≥3 classes) were more frequent in controls (p=0.02). Fewer Enterococcus (p=0.001) and E. coli (p=0.08) isolates were cultured in cases as compared to controls. The Case1 group had fewer positive urine cultures and less inpatient and outpatient healthcare utilization as compared to the Case2 or control groups (p≤0.02). 

Conclusion: Nitrofurantoin prophylaxis may reduce symptomatic UTIs in Veterans with SCI and may be considered for patients with multiple UTI-related health care encounters.

Alexander Chew, PharmD, Pharmacy, Edward Hines Jr. VA Hospital, Hines, IL, Charlesnika Evans, PhD, MPH, Center of Innovation for Complex Chronic Healthcare, Edward Hines Jr. Veterans Affairs Hospital, Hines, IL, Ursula C. Patel, PharmD, BCPS AQ-ID, Pharmacy Service, Hines VA Hospital, Department of Veterans Affairs, Hines, IL and Katie J. Suda, PharmD, Center for Innovation for Complex Chronic Healthcare, Edward Hines Jr. Veterans Affairs Hospital, Hines, IL


A. Chew, None

C. Evans, None

U. C. Patel, None

K. J. Suda, None

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.